Biblio
Found 21 results
Author Keyword [ Title] Type Year Filters: Keyword is Genetic Variation [Clear All Filters]
“Alzheimer's disease genetics: from the bench to the clinic.”, Neuron, vol. 83, no. 1, pp. 11-26, 2014.
, “Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.”, Arch Neurol, vol. 65, no. 11, pp. 1518-26, 2008.
, “Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 429-35, 2011.
, “Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.”, Nat Genet, vol. 43, no. 5, pp. 436-41, 2011.
, “Defining the Genetic Architecture of Alzheimer's Disease: Where Next.”, Neurodegener Dis, vol. 16, no. 1-2, pp. 6-11, 2016.
, “Genetic architecture of subcortical brain structures in 38,851 individuals.”, Nat Genet, vol. 51, no. 11, pp. 1624-1636, 2019.
, “Genetic association between endothelial nitric oxide synthase and Alzheimer disease.”, Clin Genet, vol. 70, no. 1, pp. 49-56, 2006.
, “Genetic association of low density lipoprotein receptor and Alzheimer's disease.”, Neurobiol Aging, vol. 26, no. 1, pp. 1-7, 2005.
, “Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure.”, Genome Med, vol. 10, no. 1, p. 43, 2018.
, “Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.”, Dement Geriatr Cogn Disord, vol. 45, no. 1-2, pp. 1-17, 2018.
, “Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.”, Nat Genet, vol. 41, no. 2, pp. 192-8, 2009.
, “A genome-wide scan for common variants affecting the rate of age-related cognitive decline.”, Neurobiol Aging, vol. 33, no. 5, pp. 1017.e1-15, 2012.
, “Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.”, Nat Genet, vol. 43, no. 7, pp. 699-705, 2011.
, “Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.”, Alzheimers Dement, vol. 12, no. 2, pp. 121-129, 2016.
, “Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease.”, Acta Neuropathol, vol. 105, no. 5, pp. 484-8, 2003.
, “A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.”, JAMA Neurol, vol. 72, no. 4, pp. 414-22, 2015.
, “Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.”, Hum Mol Genet, vol. 23, no. R1, pp. R47-53, 2014.
, “Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.”, Nature, vol. 505, no. 7484, pp. 550-554, 2014.
, “A survey of ABCA1 sequence variation confirms association with dementia.”, Hum Mutat, vol. 30, no. 9, pp. 1348-54, 2009.
, “A survey of genetic human cortical gene expression.”, Nat Genet, vol. 39, no. 12, pp. 1494-9, 2007.
, “Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.”, JAMA, vol. 309, no. 14, pp. 1483-92, 2013.
,